Cyclin D1 proteolysis: A retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells

Journal of the National Cancer Institute

Volumn 91, Issue 4, 1999, Pages 373-379

  Boyle, Jay O ^a   Langenfeld, John ^a   Lonardo, Fulvio ^a   Sekula, David ^a   Reczek, Peter ^b   Rusch, Valerie ^a   Dawson, Marcia I ^c   Dmitrovsky, Ethan ^a,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c SRI INTERNATIONAL   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CYCLOPROPYL]BENZOIC ACID; ALITRETINOIN; ALPHA CAROTENE; BETA CAROTENE; BMS 189453; CALPASTATIN; CAROTENOID; CYCLIN D1; ISOTRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; SR 11254; SR 11345; TAMIBAROTENE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0033577059     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.4.373     Document Type: Article

References (32)

1. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
2. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
3. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996;334:1561-7.
4. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145-9.
5. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
6. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
7. Langenfeld J, Lonardo F, Kiyokawa H, Passalaris T, Ahn MJ, Rusch V, et al. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation [published erratum appears in Oncogene 1996;13:2743]. Oncogene 1996;13:1983-90.
8. Langenfeld J, Kiyokawa H, Sekula D, Boyle J, Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci U S A 1997; 94:12070-4.
9. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988;48: 1904-9.
10. Lechner JF, Haugen A, McClendon IA, Pettis EW. Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. In Vitro 1982;18:633-42.
11. Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity [published erratum appears in J Med Chem 1989;32:2583]. J Med Chem 1988;31:2182-92.
12. Yu KL, Spinazze P, Ostrowski J, Currier SJ, Pack EJ, Hammer L, et al. Retinoic acid receptor β,γ-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids. J Med Chem 1996;39:2411-21.
13. Dawson MI, Jong L, Hobbs PD, Cameron JF, Chao WR, Pfahl M, et al. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem 1995; 38:3368-83.
14. Chen JY, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, et al. Two distinct actions of retinoid-receptor ligands. Nature 1996; 382:819-22.
15. Cooney RV, Kappock TJ 4th, Pung A, Bertram JS. Solubilization, cellular uptake, and activity of β-carotene and other carotenoids as inhibitors of neoplastic transformation in cultured cells. Methods Enzymol 1993;214:55-68.
16. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 1995;24:257-66.
17. Micozzi MS, Brown ED, Edwards BK, Bieri JG, Taylor PR, Khachik F, et al. Plasma carotenoid response to chronic intake of selected foods and β-carotene supplements in men. Am J Clin Nutr 1992;55:1120-5.
18. Chen GQ, Shen ZX, Wu F, Han JY, Miao JM, Zhong HJ, et al. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 1996;10:825-8.
19. Ahn MJ, Langenfeld J, Moasser MM, Rusch V, Dmitrovsky E. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene 1995;11:2357-64.
20. Roberts JM, Koff A, Polyak K, Firpo E, Collins S, Ohtsubo M, et al. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb Symp Quant Biol 1994;59:31-8.
21. 1 phase progression: cycling on cue. Cell 1994;79:551-5.
22. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994;79:547-50.
23. 1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
24. Nasmyth K. Viewpoint: putting the cell cycle in order. Science 1996;274:1643-5.
25. Kip1. Mol Cell Biol 1995;15: 4347-52.
26. Betticher DC, Heighway J, Hasleton PS, Allermatt HJ, Ryder WD, Cerny T, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996;73: 294-300.
27. Betticher DC, Heighway J, Thatcher N, Hasleton PS. Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 1997;75: 1761-8.
28. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997;57:2331-5.
29. Bockmuhl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in high-and low-grade head and neck squamous cell carcinomas. Cancer Res 1996;56: 5325-9.
30. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-10.
31. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, et al. Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis. Cancer Res 1997;57:4992-6.
32. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83: 841-50.